Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.51 |
| ▸ | C3AR1 | Q16581 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | NOS2 | P35228 | 1/20 | 0.49 |
| ▸ | NPY1R | P25929 | 3/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NPY4R | P50391 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31110298 | 0.95 | C3AR1 (0.54) | C3AR1CYP1A2GLATSHRNFKB1 | |
| SCHEMBL31110300 | 0.95 | C3AR1 (0.54) | C3AR1CYP1A2GLATSHRNFKB1 | |
| SCHEMBL29566514 | 0.94 | NPY1R (0.52) | C3AR1CYP1A2GLATSHRNFKB1 | |
| SCHEMBL29794337 | 0.91 | CYP2C19 (0.56) | GNPATC3AR1CYP1A2GLATSHR | |
| SCHEMBL1736266 | 0.90 | NPY1R (0.55) | GNPATC3AR1CYP1A2GLATSHR | |
| SCHEMBL29611117 | 0.90 | CYP2C19 (0.58) | C3AR1CYP1A2GLATSHRNFKB1 | |
| SCHEMBL29613341 | 0.88 | CYP2C19 (0.59) | GNPATC3AR1CYP1A2GLATSHR | |
| SCHEMBL1736416 | 0.88 | CYP2C19 (0.59) | GNPATC3AR1CYP1A2GLATSHR | |
| SCHEMBL1736042 | 0.88 | CYP2C19 (0.59) | GNPATC3AR1CYP1A2GLATSHR | |
| SCHEMBL29355798 | 0.87 | NPY1R (0.51) | GNPATC3AR1CYP1A2GLATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360156-A1 | SYNERGISTIC COMBINATION OF NAD+ AND THERAPEUTIC PEPTIDES DELIVERED VIA IONTOPHORESIS FOR ENHANCED AND PROLONGED REGENERATIVE EFFECTS | ANDREWS NICHOLAS JEROME (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250281531-A1 | METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS | MDLifespan Enterprises, LLC | 2025-09-11 | — | — | US | disclosed |
| US-20250034545-A1 | MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY | KAI PHARMACEUTICALS, INC. | 2025-01-30 | — | — | US | disclosed |
| CN-111352826-B | Automatic interface test case generation method and tool | 上海云扩信息科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-20220282239-A1 | MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY | KAI PHARMACEUTICALS, INC. | 2022-09-08 | — | — | US | disclosed |